Evidence reviews – November 2019
The following documents contain the evidence that was used to develop the 2019 recommendations:
- Reducing recurrent short-term sickness absence
- Reducing movement from short-term to long-term sickness absence
- Facilitating the return to work of employees on long-term sickness absence and reducing risk of recurrence
- Cost effectiveness outcomes
This page was last updated: